EVOK — Evoke Pharma Share News
0.000.00%
Last trade - 00:00- $18.86m
- $12.28m
- $10.25m
Evoke Pharma Inc reports results for the quarter ended in June - Earnings Summary
UK Stocks-Factors to watch on Aug 15
Evoke Pharma Inc expected to post a loss of 72 cents a share - Earnings Preview
Europe Research Roundup: Anglo American, Rio Tinto, Unilever
Brief: Evoke Pharma Appoints Mark Kowieski As CFO
Brief: Evoke Pharma Has Appointed Mark Kowieski As CFO
Evoke Pharma Inc reports results for the quarter ended in January - Earnings Summary
Brief: Evoke Pharma Says Audit Committee Determined Previously Issued Financials Should No Longer Be Relied Upon
Evoke Pharma Inc expected to post a loss of 21 cents a share - Earnings Preview
Evoke Pharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: Laurence W. Lytton Reports 9.99% Passive Stake In Evoke Pharma As Of Feb 9, 2024- SEC Filing
Evoke Pharma Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Evoke Pharma - In Accordance With Nasdaq Listing Rule 5810(C)(3)(A), Co Has Been Provided Initial Period Of 180 Calendar Days To Regain Compliance
Brief: Evoke Pharma Announces FDA Orange Book Listing Of New Gimoti Patent
Evoke Pharma Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Evoke Pharma Receives Notice Of Allowance From Uspto For Gimoti
Evoke Pharma Inc reports results for the quarter ended in June - Earnings Summary
Evoke Pharma Inc expected to post a loss of 73 cents a share - Earnings Preview
Brief: Evoke Pharma Inc Says Nasdaq Granted Extension